Thyrogen is currently available in more than 45 countries. It was first approved in the United States in 1998 for use in patients with well- differentiated thyroid cancer who have had their thyroid ...

A drug shortage has been solved. Genzyme is now able to supply its thyroid cancer treatment, Thyrogen, even as it moves further into thyroid cancer treatment with a new biomarker that helps doctors ...

The FDA has approved the use of Thyrogen (thyrotropin alfa for injection) to be used in combination with radioiodine to ablate or destroy any remaining thyroid tissue in patients who have had ...

PROVIDENCE, R.I. – A two-week low-iodine diet is necessary for adequate outpatient preparation for 131-I thyrogen scanning in patients taking levothyroxine, according to a recent study sponsored by ...

Genzyme, a Sanofi company, announced that its supply of Thyrogen (thyrotropin alfa for injection) has been fully stored due to the continued progress in its manufacturing operations. Thyrogen is ...

Sanofi's ($SNY) biotech unit Genzyme is recalling more than 36,000 vials of its thyroid cancer drug Thyrogen from the U.S., Puerto Rico and four other countries ...

Thyrogen market Report 2025 – Market Size, Trends, And Forecast 2025-2034 The Business Research Company's Thyrogen Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 Updated 2025 ...